Pentobarbital withdrawal and treatment in an infant in the pediatric cardiac intensive care unit.
Garret M Weber, Arthur J Smerling, John M Saroyan
Index: J. Clin. Anesth. 25(1) , 62-5, (2013)
Full Text: HTML
Abstract
Withdrawal syndromes following administration of sedative and analgesic infusions represent a significant morbidity that is described increasingly in the pediatric critical care literature. However, there are few descriptions of pentobarbital withdrawal symptoms and their treatment in the pediatric population. We describe an infant receiving multiple sedative and analgesic medications, including pentobarbital, who was resistant to our institution's standard weaning protocol, but whose severe withdrawal symptoms responded dramatically to phenobarbital loading and maintenance.Copyright © 2013 Elsevier Inc. All rights reserved.
Related Compounds
Related Articles:
The slow death of lethal injection.
2014-04-01
[BMJ 348 , g2670, (2014)]
Ascorbic acid reverses the prolonged anesthetic action of pentobarbital in Akr1a-knockout mice.
2014-01-24
[Life Sci. 95(1) , 1-8, (2014)]
2013-04-01
[Lab. Anim. 47(2) , 122-6, (2013)]
Hemodiafiltration in pentobarbital poisoning.
1996-03-01
[Ren. Fail. 18(2) , 299-303, (1996)]
2013-02-28
[Chin. J. Physiol. 56(1) , 44-51, (2013)]